Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Contact information


edward.oneill@nds.ox.ac.uk


ORCID ID https://orcid.org/0000-0002-7987-8160


Radiobiology Research Institute, Churchill Hospital, Oxford, OX3 7LJ

Collaborators

Edward O'Neill

BSc (Hons), PhD

PCUK Career Acceleration Fellow

Research Summary

My research focuses on improving radionuclide therapy for treatment of prostate cancer. While targeted radionuclide treatments such as 177Lu-PSMA are promising new treatments for men with metastatic prostate cancer, we cannot yet promise they will work despite sufficient tumour uptake.

I am investigating why these treatments may not work to their full potential by investigating the underlying radiobiological response to radionuclide therapy in models of prostate cancer. My research uses both drug combination screens and preclinical imaging to probe this underlying radiobiology to identify new hybrid imaging and chemo-radionuclide treatment strategies to overcome treatment resistance in the clinic.